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Abstract
Background:  Type  1  diabetes  (T1D)  is  currently  an  autoimmune  disease  occurring  more  fre-
quently and  early  in  life.  T1D  development  requires  genetic  predisposition  and  environmental
factors, which  inﬂuence  the  gut  microbiota  in  early  infancy  and  could  increase  the  risk  for
T1D-associated  autoimmunity.  In  Mexico  there  are  no  published  microbiota  studies  in  children
<6 years  old  with  T1D.
Case  reports: We  report  two  contrasting  Mexican  T1D  cases  of  children  <6  years  of  age  and  a
third case  of  a  healthy  child  prior  to  autoimmunity  and  T1D  onset.  Perinatal  factors,  feeding
regimes  in  the  ﬁrst  year  of  life  and  gut  microbiota  composition  are  discussed  and  related  to
the T1D  onset.  The  three  cases  show  a  particular  microbiota  proﬁle  with  decreased  bacterial
diversity  as  compared  with  healthy  children,  which  could  be  related  to  environmental  factors
prior to  the  development  of  T1D  and  disease  control.
Conclusions:  T1D  infant  cases  presented  a  decreased  bacterial  diversity,  which  appeared  before
autoimmunity  and  T1D  onset.  Glycemic  control  could  tend  to  correct  the  gut  dysbiosis  in  T1D
children. Prospective  studies  are  needed  to  follow-up  healthy  children  at  high  genetic  risk  to
assess factors  related  to  the  microbiota  structure.
© 2015  Hospital  Infantil  de  México  Federico  Gómez.  Published  by  Masson  Doyma  México
S.A. This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
PALABRAS  CLAVE
Diabetes  tipo  1;
Factores  perinatales  y  disbiosis  asociada  con  diabetes  tipo  1  en  nin˜os  mexicanos
tipo  1  (DT1)  es  una  enfermedad  autoinmune  que  cada  vez  es  más
edades  más  tempranas.  Su  desarrollo  requiere  de  predisposición
ntales  que  inﬂuyen  sobre  la  microbiota  intestinal  en  la  infanciaFactores  perinatales;
Lactancia  materna;
Microbiota  intestinal;
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temprana  que  pudieran  aumentar  el  riesgo  de  autoinmunidad  asociada  con  DT1.  En  México  no
existen publicaciones  de  estudios  de  microbiota  en  nin˜os  menores  de  6  an˜os  con  DT1.
Casos clínicos: Se  reportan  dos  casos  de  DT1  contrastantes  de  nin˜os  mexicanos  menores  de  6
an˜os de  edad  y  un  tercer  caso  de  un  nin˜o  sano,  previo  al  desarrollo  de  autoinmunidad  y  DT1.
Se discuten  los  factores  perinatales,  los  regímenes  de  alimentación  en  el  primer  an˜o  de  vida
y la  microbiota  intestinal  en  relación  con  el  desarrollo  de  DT1.  Los  tres  casos  presentaron  una
microbiota  particular  con  disminución  de  la  diversidad  bacteriana  en  comparación  con  los  nin˜os
sanos, lo  cual  pudiera  estar  relacionado  con  factores  ambientales  previos  al  desarrollo  de  la
enfermedad  y  con  el  control  de  la  DT1.
Conclusiones:  Los  nin˜os  con  DT1  presentaron  una  diversidad  bacteriana  disminuida  que  aparece
antes de  la  autoinmunidad  y  DT1.  El  control  glucémico  podría  corregir  la  disbiosis  intestinal  en
DT1. Faltan  estudios  prospectivos  que  den  seguimiento  a  nin˜os  sanos  con  alto  riesgo  genético  y
evalúen factores  relacionados  con  la  estructura  de  la  microbiota.
© 2015  Hospital  Infantil  de  México  Federico  Gómez.  Publicado  por  Masson  Doyma  México
S.A. Este  es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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p. Introduction
ype  1  diabetes  (T1D)  is  one  of  the  most  frequent  autoim-
une  diseases  in  children  with  a  prevalence  of  1:3001.
dvances  in  the  study  of  predisposition  factors  during  the
ast  decade  increase  the  evidence  of  an  intestinal  origin  for
1D  which,  in  turn,  reveals  an  unexplored  area  for  under-
tanding  the  diabetes  etiology.  The  interplay  between  early
eeding  patterns,  infections  and  use  of  antibiotics  during
he  ﬁrst  years  of  life  has  taken  a  central  role  because  all
nﬂuence  the  microbiota  composition  and  gut  permeabil-
ty.  Associations  have  been  found  in  animal  models  of  the
nteractions  of  these  factors  in  relation  to  the  develop-
ent  of  T1D2.  Although  the  ﬁrst  studies  in  children  at  high
enetic  risk  have  shown  gut  dysbiosis  at  the  T1D  onset,
hese  changes  are  affected  by  diet,  geography3 and  other
actors  such  as  age4.  Furthermore,  it  is  unknown  whether
hese  changes  in  microbiota  are  a  cause  or  an  effect  of  the
haracteristic  metabolic  disturbance  of  T1D.
We  report  a  case  series  of  two  contrasting  Mexican  T1D
atients  (6  years  old  and  younger)  and  a  third  case  of
 healthy  child  prior  to  autoimmunity  and  T1D  onset,  all
ecruited  from  the  Children’s  Hospital  of  Sonora  (HIES),
exico.  Elements  of  their  diet  in  the  ﬁrst  year  of  life
nd  perinatal  factors  are  discussed  and  related  to  the  T1D
iagnosis  and  the  gut  microbiota  composition,  assessed  by
yrosequencing  of  the  V4  region  of  the  16S  rRNA  gene  fol-
owing  the  methods  described  previously5.  Microbiota  data
f  the  cases  were  processed  and  analyzed  in  the  Quantitative
nsights  Into  Microbial  Ecology  (QIIME)  pipeline6.
. Case reports
.1.  Case  1
e  present  the  case  of  a  6-year-old  female  with  3  days
volution  of  T1D  diagnosed  when  she  was  hospitalized
or  diabetic  ketoacidosis  (glucose:  538  mg/dl).  The  patient
as  the  product  of  a  ﬁfth  pregnancy  complicated  with
ligo-hydramnios  and  fetal  distress.  The  mother  was  a
assive  smoker  during  pregnancy.  The  patient  was  born
b
p
c
waginally  at  38  weeks  of  gestation  and  breastfed  until  2
onths  of  age.  She  had  complementary  milk  formula  since
irth.  At  6  months  of  age,  wheat  and  other  cereals  were
ntroduced  into  her  diet.  Since  the  ﬁrst  year,  the  child  pre-
ented  an  average  of  six  infections  per  year  (respiratory
nd  gastrointestinal)  treated  with  antibiotics  (amoxicillin,
rimethoprim/sulfamethoxazole,  and  cephalexin).  She  suf-
ered  from  acute  tonsillitis  2  weeks  prior  to  the  diagnosis  of
1D.
T1D-associated  autoantibodies  were  as  follows:  positive
o  anti-glutamic  acid  decarboxylase  (Anti-GAD)  and  anti-
yrosine  phosphatase-like  protein  (Anti-IA2).
Risk  phenotype  was  DRB1*04/DQA1*0301.
.2.  Case  2
his  is  the  case  of  a  2-year-old  female  with  T1D  diagnosed
.5  months  before  the  study.  She  has  had  excellent  adher-
nce  to  treatment  with  insulin  and  diet.  She  was  born  by
utocic  vaginal  delivery  without  perinatal  complications.
he  had  a  mixed  feeding  regimen  with  breast  milk  and
ormula  from  birth  to  2  months  old,  continuing  only
ith  cow’s  milk  formula.  Wheat  and  other  cereals  were
ntroduced  into  her  diet  when  she  was  2  months  old.  She
uffered  two  respiratory  and  four  gastrointestinal  infec-
ions  of  unknown  etiology  during  her  ﬁrst  year  of  life.
ll  diseases  were  treated  with  antibiotics  (amoxicillin,
rimethoprim/sulfamethoxazole).  Current  fasting  glucose
as  reported  as  105  mg/dl.  T1D-associated  autoantibodies
ere  positive  to  Anti-IA2.
Risk  phenotype  was  DRB1*03/DR4-DQ8.
.3.  Case  3
e  present  the  case  of  a 6-year-old  male  who  was  healthy
t  the  time  of  the  study.  His  brother  is  a  T1D  patient.  The
atient  is  the  term  product  of  a  second  pregnancy  born
y  cesarean  due  to  cephalo-pelvic  disproportion,  without
erinatal  complications.  He  was  breastfed  for  3  months,
ontinuing  with  cow’s  milk  formula  since  that  age  until  he
as  1  year  old.  Cereals  such  as  wheat  were  introduced  to
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his  diet  at  2  months  old.  He  presented  an  average  of  three
infectious  episodes  per  year  treated  with  antibiotics  (mainly
amoxicillin).  T1D-associated  autoantibodies  were  negative
to  Anti-GAD  and  Anti-IA2.
Risk  phenotype  was  DR3-DQ2/DQB1*0302.
2.4.  Investigation  and  follow-up
A  stool  sample  was  collected  from  each  case  from  which
gDNA  was  extracted  to  study  the  microbiota  composition  by
pyrosequencing.  Analysis  of  the  intestinal  microbiota  identi-
ﬁed  a  total  of  8,758  bacterial  sequences  in  the  fecal  sample
of  case  1,  8,698  sequences  in  case  2  and  6,905  in  case  3.
The  most  dominant  phylum  in  case  1  and  2  was  Bac-
teroidetes  followed  by  Firmicutes  with  a  ratio  of  2:1.
However,  at  the  genus  level  the  differences  arose.  Thus,
58.9%  of  the  gut  microbiota  from  case  1  corresponded  to
the  Prevotella  genus  (Bacteroidetes),  whereas  in  case  2  the
most  prevalent  was  Bacteroides  (Bacteroidetes)  with  44.5%.
These  genres  were  followed  in  abundance  by  11.1%  Meg-
amonas  (Firmicutes),  3.6%  Escherichia  and  3.1%  Suterella
(Proteobacteria).  Meanwhile,  in  case  2  the  predominant  Fir-
micutes  groups  were  the  Lachnospiraceae  family  with  13%
and  the  genus  Oscillospira  with  7%  (Figure  1).
In  contrast,  case  3  presented  an  inverse  Bac-
teroidetes/Firmicutes  ratio  of  1:3.  The  Ruminococcaceae
(Firmicutes)  family  is  highlighted  with  a  relative  abundance
of  44%  including  the  genus  Oscillospira  and  Ruminococcus.
Regarding  Bacteroidetes,  9.4%  of  Bacteroides  and  7.6%  of
Prevotella  genus  were  found  (Figure  1).
Case  3  developed  T1D  1  year  later,  with  fasting  glucose  of
372  mg/dl  at  onset  and  classic  diabetes  symptoms  (polypha-
gia,  polydipsia  and  polyuria).
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Figure  1  Relative  abundance  of  fecal  bacterial  genera  in  each  sub
included. All  operational  taxonomic  units  (OTUs)  with  lower  abundan
3, HC1:  Healthy  children  1,  HC2:  Healthy  children  2.ican  infants  335
.  Discussion
he  perinatal  period  is  critical  for  the  development  of
he  individual  microbiota.  The  shape  of  the  newborn  ﬁrst
icrobiota  depends  directly  on  the  delivery  mode.  Children
orn  vaginally  have  a  vertical  transfer  of  maternal  vaginal
acteria  such  as  Lactobacillus  and  Prevotella  spp.  On  the
ther  hand,  those  born  by  cesarean  acquire  microorganism
rom  the  skin  and  operating  room  such  as  Staphylococ-
us,  Corynebacterium  and  Propionibacterium  spp.7.  After
elivery,  the  feeding  regimes  are  crucial  to  promote  the
evelopment  of  a  diverse  and  healthy  microbiota.  Current
ecommendations  based  on  evidence  are  focused  on  the
aintenance  of  breastfeeding  for  at  least  the  ﬁrst  6  months,
deally  continuing  it  throughout  the  ﬁrst  year  of  life  and
he  introduction  of  cereals  into  the  infant’s  diet  between  4
nd  6  months  of  age.  These  actions  promote  the  decrease
n  the  risk  for  developing  autoimmune  diseases  and  aller-
ies  in  childhood.  Thus,  exclusive  breastfeeding  longer  than
 months  or  total  breastfeeding  longer  than  7  months  are
ndependent  protective  factors  against  T1D  development8.
Here  we  presented  two  cases  of  T1D  patients  that  share
isk  factors  such  as  the  inadequacy  of  their  feeding  regimes
uring  the  ﬁrst  year  of  life,  even  though  they  were  born
y  vaginal  delivery.  None  received  an  exclusively  breastfed
egimen  and  they  were  fed  with  cow  milk  formula  as  new-
orns.  Furthermore,  case  2  and  case  3  have  in  common  the
ntroduction  of  wheat  to  their  feeding  regimen  at  2  months
ld  without  gradually  scaling  portions.
The  three  cases  are  compared  with  two  healthy  Mexican
hildren  (3  and  5  years  old)  recruited  from  the  same  popu-
ation  and  who  were  negative  for  HLA  haplotypes  DR3-DQ2
nd  DR4-DQ8  (Figure  2).  Both  healthy  children  were  born
aginally,  breastfed  for  more  than  6  months  and  cereals,
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ject.  Only  phyla  and  genera  with  relative  abundance  >1%  were
ce  were  grouped  as  ‘‘other’’.  C1:  case  1,  C2:  case  2,  C3:  case
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Figure  2  (A)  Rarefaction  curve  of  observed  species  in  fecal  samples  from  cases  and  two  healthy  reference  children.  (B)  Com-
munities’ clustered  using  Principal  Coordinates  analysis  of  the  unweighted  UniFrac  distance  matrix.  The  percentage  of  variation
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ase 2,  C3:  case  3,  HC1:  Healthy  children  1,  HC2:  Healthy  child
ncluding  wheat,  were  introduced  into  their  diet  when  they
ere  about  5-6  months  old.
Therefore,  as  they  were  close  to  the  current  recommen-
ations,  for  purposes  of  this  analysis,  their  microbiota  was
onsidered  as  a  reference  of  what  might  be  the  normal  gut
acterial  proportions  under  optimal  conditions  in  children
f  this  age  range  in  the  study  region  (Sonora,  Mexico).
This  is  an  important  consideration  to  contextualize  the
resented  cases  because  the  microbiome  of  T1D  high-risk
nfants  is  associated  with  geographic  location.  Kemp-
3ainen  et  al. found  great  variability  in  the  structure  and
iversity  of  gut  microbiomes  among  countries  and  conti-
ents,  even  in  populations  with  homogeneous  HLA  class  II
enotypes.
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tarenthesis  on  the  axes.  T1D:  Type  1  diabetes,  C1:  case  1,  C2:
.
It  is  evident  that  the  intestinal  microbiota  of  healthy  Mex-
can  infants  where  Bacteroides  genus  is  the  most  abundant  is
ery  homogeneous  (intragroup  diversity)  and  different  from
he  one  dominated  by  Prevotella  of  case  1.  Additionally,
t  is  also  different  from  that  found  in  healthy  children  >7
ears  old  from  the  same  region5.  It  is  necessary  to  highlight
hat  case  2  has  a composition  pattern  closer  to  the  healthy
hildren  than  the  other  T1D  patient  (Figures  1  and  2).
he  contrast  found  between  case  1  and  case  2  is  proba-
ly  because  case  1  is  a  decompensated  patient  in  the  stage
f  diagnosis,  metabolically  unbalanced  and  coursed  with
ncontrolled  glucose  levels.  Meanwhile,  case  2  is  a  patient
n  a  stable  phase  of  the  disease  with  glucose  levels  closer  to
he  normal  range.
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Previous  studies  linked  uncontrolled  glucose  levels  with
the  microbiota  imbalance  associated  with  T1D  and  dysbiosis
tends  to  be  restored  after  control  of  the  disease  with  insulin
treatment  for  >2  years5.  This  would  indicate  that  case  2  was
able  to  partially  restore  the  balance  of  her  microbiota  in  <3
months  when  she  achieved  the  control  of  T1D  with  insulin
and  nutritional  management.  Further  prospective  studies
are  needed  to  prove  this  statement.
One  of  the  similarities  between  case  1  and  case  2  is
that  they  have  higher  levels  of  the  Enterobacteriaceae
genus  Klebsiella  and  Escherichia.  Both  are  pathobionts,  i.e.,
despite  being  commensal  microorganisms  they  have  the
potential  of  causing  disease  and  therefore  could  activate  or
maintain  metabolic  pathways  that  promote  inﬂammation.
Elevated  levels  of  Escherichia  have  been  associated  in  other
studies  with  the  consumption  of  infant  formula  in  bottle-fed
children9.
Case  3  presented  high  risk  factors  for  the  development
of  autoimmunity  associated  with  T1D,  including  a  very  high-
risk  phenotype.  His  microbiota  structure  appears  to  be
different  from  both  T1D  cases  and  from  the  one  of  the
reference  children.  It  also  showed  an  inverse  ratio  for  Fir-
micutes/Bacteroidetes  when  compared  to  healthy  Mexican
children,  but  also  to  those  already  diagnosed  with  T1D.
This  alteration  apparently  occurs  prior  to  the  development
of  autoimmunity  and  T1D  and  is  reﬂected  as  a  decrease
in  microbial  diversity  (Figure  2A)  without  being  as  limited
as  in  T1D.  These  results  are  in  part  different  from  those
reported  by  Kostic  et  al.4 where  the  changes  were  displayed
after  development  of  autoimmunity,  prior  to  T1D  diagnosis.
However,  we  only  evaluated  Anti-GAD  and  Anti-IA2  autoan-
tibodies  and  not  IAA,  ZNT8A  and  ICA  as  done  by  Kostic  et  al.4
Based  on  these  observations,  in  this  process  Oscillospira
and  Ruminococcus  could  be  involved.  Case  3  presented
higher  levels  of  these  bacterial  genera  with  respect  to  the
healthy  children.  These  ﬁndings  are  consistent  with  results
in  NOD  mice10 where  levels  of  Ruminococcus  and  Oscillospira
had  an  inverse  relationship  with  T1D  age  of  onset.  Related
to  this,  de  Goffau  et  al.11 found  that  in  young  European
children  between  3  and  5  years  old,  Ruminococcus  obeum
was  positively  correlated  with  the  recent  development
of  T1D.  However,  the  remaining  microbiota  composition
of  these  children  differs  from  that  found  in  the  Mexican
cases.
Case  3  could  be  an  example  of  how  diet  and  envi-
ronmental  factors  in  early  life  could  establish  an  adverse
environment,  which  promotes  the  development  of  autoim-
munity  in  children  with  genetic  susceptibility.  During  the
ﬁrst  three  years  of  life,  the  shaping  of  the  immature  micro-
biota  into  an  adult-like  composition  could  be  directed  in
an  aberrant  direction11 if  these  factors  are  not  taken  into
account  in  the  infants.  This  idea  is  supported  by  the  fact  that
although  the  intestinal  microbiota  of  infants  is  very  unsta-
ble,  microorganisms  acquired  in  the  ﬁrst  year  of  life  are
preserved  throughout  childhood,  at  least  up  to  3  years  when
the  T1D-associated  autoimmunity  mainly  begins  to  appear.
Likewise,  despite  abundance  of  variations,  the  metabolic
pathways  associated  with  the  microbiota  remain  over  time4.
These  early  ﬁndings  complement  our  results  from  another
study  with  a  larger  sample  of  older  T1D  children5.  Together
they  may  provide  the  basis  for  the  design  and  future
implementation  of  primary  prevention  strategies  for  T1D,ican  infants  337
ustomized  according  to  the  geographic  origins  and  charac-
eristics  of  the  groups  at  risk.
In conclusion,  fecal  microbiota  of  the  presented  cases
ppears  to  be  different  from  the  one  of  healthy  infants  con-
idered  as  reference.  This  could  be  related  to  the  feeding
atterns  and  environmental  factors  prior  to  the  develop-
ent  of  autoimmunity  and  T1D.  Prospective  studies  are
eeded  to  follow-up  on  healthy  children  at  high  genetic  risk,
o  assess  their  perinatal  history,  diet  and  fecal  microbiota  in
elation  to  their  place  of  origin.
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